MAPT and Alzheimer disease: The use of positron emission tomography (PET) imaging with [F-18]AV-1451 ([F-18]T807; Flortaucipir, AVID Radiopharmaceuticals), a tau specific tracer, allows the detection of abnormal aggregates of phosphorylated tau protein in vivo in AD [Marquié et al., 2015].